Volver a Agenda
Session Chair(s)
Gregg Schneider
Director, R&D Financial Management
Otsuka Pharmaceutical Development & Commercialization, Inc., United States
Learning Objective : Assess adaptive design options at each phase of development; Discuss the specifics of portfolio planning for a generic company.
Speaker(s)
Adopting an Adaptive Design Strategy to Manage Portfolio Risk and Value
Sarah Arbe-Barnes, PHD
Aptiv Solutions, United States
Portfolio Optimization for a Generic Drug Company
Vladimir Shnaydman, PHD, MSC
ORBee Consulting, United States
President
¿Tiene una cuenta?